UK's only green hydrogen heating trial delayed by up to a year amid 'supply-chain and procurement challenges'
But installation work on H100 Fife’s dedicated electrolysis system has now begun
Stay ahead on hydrogen with our free newsletter
The H100 Fife project — in the town of Buckhaven, in the Fife region of eastern Scotland — has fallen prey to supply-chain challenges, gas company SGN said, without giving any further details.
“It’s taking longer than we planned to deliver this world-first project which has faced supply chain and procurement challenges,” the company stated in an update on its H100 Fife website.
So far, the project’s 8.5km new hydrogen network is 65% finished, while the foundations of SGN’s green hydrogen production facility are complete and work on the project’s electrolysis system is now under way.
The H100 electrolyser will be powered by a 7MW demonstration offshore wind turbine owned by UK government-backed research institute Offshore Renewable Energy (ORE) Catapult, which is currently supplying electricity to local homes.
But while two similar hydrogen heating trial programmes in England were abandoned last year in the face of rebellions from residents, the H100 Fife programme appears to have escaped significant public opposition.
And although the project has promised trial participants that they will pay not more for hydrogen heating than they would for natural gas, hydrogen is generally at least three times more expensive than gas.
Nevertheless, SGN says that H100 Fife enjoys the support of the local community.
“We continue to have great support from the community in Buckhaven and Denbeath and are committed to ensuring that residents taking part in H100 Fife receive a first-class customer experience as they lead the world in this ground-breaking green project.”
The lack of opposition could be due to the fact that the project includes its own dedicated hydrogen pipeline system, meaning that households that do not want to participate can continue using their gas supply, meaning that inclusion in the trial is completely voluntary.